The effect of CYP3A5 genetic polymorphisms on adverse events in patients with ulcerative colitis treated with tacrolimus-Reference-Cited by-同舟云学术

The effect of CYP3A5 genetic polymorphisms on adverse events in patients with ulcerative colitis treated with tacrolimus

Published:2017-01 Issue:1 Volume:49 Page:24-28
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Asada Ayumi,Bamba Shigeki,Morita Yukihiro,Takahashi Kenichiro,Imaeda Hirotsugu,Nishida Atsushi,Inatomi Osamu,Sugimoto Mitsushige,Sasaki Masaya,Andoh Akira

Funder

Ministry of Education, Culture, Sports, Science and Technology of Japan

Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan

Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and development, AMED

Smoking Research Foundation

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference24 articles.

1. New pathophysiological insights and modern treatment of IBD;Engel;Journal of Gastroenterology,2010

2. The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease;Naganuma;Journal of Gastroenterology,2011

3. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis;Ogata;Gut,2006

4. Specialty practice series: intrapatient variability with tacrolimus;Cervelli;The Australian Journal of Pharmacy,2012

5. The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation;Hesselink;Clinical Pharmacokinetics,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of cytochrome P450 3A genetic polymorphisms on tacrolimus pharmacokinetics in ulcerative colitis patients;PLOS ONE;2021-04-22

2. Effect of Antibiotic Susceptibility and CYP3A4/5 and CYP2C19 Genotype on the Outcome of Vonoprazan-Containing Helicobacter pylori Eradication Therapy;Antibiotics;2020-09-26

3. Programmed death-ligand 1 single nucleotide polymorphism affects breast cancer chemosensitivity and adverse events in the neoadjuvant setting;The International Journal of Biological Markers;2020-09

Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy

;Pharmacogenomics and Personalized Medicine;2020-04

5. Role of cytochrome P450 polymorphisms and functions in development of ulcerative colitis;World Journal of Gastroenterology;2019-06-21